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Breast-feeding, using family or small-group day care for infants and toddlers and avoiding exposure to household 
tobacco smoke are the main preventive measures against acute otitis media (AOM). It is also useful t o  immunize children 
who have recurrent otitis media with the influenza and the pneumococcal vaccines. Antibiotic prophylaxis is the most 
effective method to  reduce the frequency of new episodes of otitis in  children with recurrent AOM, but it should be used 
with caution. Tympanostomy tube placement and/or adenoidectomy can be considered as options in  some situations. 
Now, probably, the best initial steps to  take to  prevent new episodes of otitis in children with recurrent AOM are 
antimicrobial treatment of each individual AOM episode and, in certain cases, antibiotic prophylaxis for short periods 
when an upper respiratory tract infection is present. 
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In order to establish effective measures to prevent 
acute otitis media (AOM), it is essential to know the 
epidemiologic and personal factors prehsposing a child 
to acquire AOM. Infants and toddlers are at greater risk 
of AOM than are older children. The highest incidence 
of AOM is between the ages of 6 and 15 months [ 1-31, 
The basis for this age-related predisposition is poorly 
understood, but it is likely to be related to particular 
characteristics of nasopharynx anatomy, eustachian 
tube function or immune response which we cannot 
modify at present [4-61. 
One very important factor predicting the pro- 
bability of AOM recurrence is the age when the child 
has the first otitis media: the younger the child at the 
first episode, the more likely is recurrence [2]. 
Breast-fed infants have less prevalence of AOM and 
less risk of recurrence than do formula-fed infants 
[1,2,7]. The benefits of breast-feeding are particularly 
apparent during the first year of life and are present 
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even when weaning occurs after only a few months. 
This protective effect appears to be greater, however, 
the longer breast-feeding lasts [8], providing an objective 
reason to recommend breast-feeding systematically. 
Upper respiratory tract infections constitute a clear 
predisposing factor for AOM [9, lo]. Otitis media is the 
most frequent complication of viral upper respiratory 
tract infections, occurring at rates between 15% and 
25% in infants and between 2% and 5% in older 
children [ll]. Therefore, any steps to reduce and 
control such viral infections will lead to a decrease in 
AOM incidence. 
Institutional day-care arrangements for infants and 
toddlers increase the risk ofAOM [12-141, just as they 
lead to a higher incidence of upper respiratory tract 
infection. Delaying the day care of younger children, 
and avoiding large day-care centers for those who suffer 
upper respiratory tract infections and otitis media easily, 
decreases the number of AOM episodes [ 15,161. 
Children who are passive smokers are more prone 
to AOM during the first year of life, and have middle 
ear effusion longer [17]. It is therefore desirable to avoid 
household exposure to tobacco smoke, particularly in 
children showing a tendency to acquire AOM. 
Another risk factor for AOM is a family history 
of recurrent AOM in a sibling [2,18]. Children with 
submucous or frank cleft palates also have a high risk 
of AOM [19]. In both cases it will be necessary to 
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make every effort to take all known primary preventive 
measures. 
Respiratory and food allergies have been said to 
raise the risk of AOM, but no clinical association has 
ever been firmly established [20,21]. Consequently we 
have no information about potential preventive actions 
in this area. 
For children with recurrent AOM, it is suitable to 
take an active approach to preventing new episodes. 
Recurrent AOM requiring some type of preventive 
measure is considered to exist when three or more 
episodes occur in the previous 6 months or when 
four episodes occur within a year [22,23]. Preventive 
approaches which have been suggested include anti- 
biotic prophylaxis, tympanostomy tube placement, 
adenoidectomy and antimicrobial vaccines [24,25]. 
ANTIBIOTIC PROPHYLAXIS 
Because of the variety of bacterial organisms involved 
in the etiology of AOM, it is necessary to opt for 
rather broad-spectrum antibiotics for prophylaxis. 
Amoxicillin, sulfisoxazole and trimethoprim-sulfa- 
methoxazole are the most commonly employed world- 
wide [22,25]. The antimicrobial drug is given on a 
once- or twice-daily basis and at a lower dose than usual 
(one half or one third the standard dosage), for 3-6 
months. The effectiveness of such prophylaxis in re- 
ducing the frequency of AOM is attributable to the 
presence of the antibiotic in nasopharynx, eustachian 
tube and middle ear tissues in sufficient concentration 
and for enough time to keep the burden of pathogenic 
bacteria below the levels which would lead to infection 
A meta-analysis of several randomized, controlled 
trials with a total of 958 subjects compared the rates 
of occurrence of AOM in children who received 
antibiotic prophylaxis or placebo [26]. Antibiotics 
reduced the frequency of new episodes of otitis by 
44% in comparison with the placebo groups. The mean 
difference was a decrease of 0.11 in the number of otitis 
episodes per patient-month for children who received 
antibiotics, as compared with controls. But the pro- 
portion of time with middle ear effusion (subclinical 
secretory otitis media) did not seem to change with 
antibiotic prophylaxis [27]. Thus, antimicrobial prophy- 
laxis appears to reduce the rate of symptomatic disease, 
but does not affect the underlying disease process [25], 
and its main application would therefore be in cases 
of recurrent AOM in which the middle ear remains 
effusion-free between episodes [28]. 
The administration of antibiotics at the onset of 
each upper respiratory infection, beginning at the 
first symptom and continuing until the infection has 
~ 4 1 .  
resolved, can also prevent episodes of otitis [29,30]. 
This strategy appears to be somewhat less effective 
than daily continuous prophylaxis during the winter 
respiratory-infection season but is likely to be equally 
effective when the frequency of upper respiratory tract 
infections and otitis decreases [22]. 
The potential adverse drug reactions and, especially, 
the rising emergence of multiple-antibiotic-resistant 
bacteria mean, however, that the recommendation for 
continuous antibiotic prophylaxis as the initial approach 
to the prevention of recurrent AOM should be revised 
[23]. In particular, the increasing prevalence of Strepto- 
coccus pneumoniae resistant to penicillin and other 
antibiotics (including macrolides and cephalosporins), 
and Haemophilus inzuenzae resistant to ampicillin and 
sulfonamide-a development directly related to the use 
of antimicrobial prophylaxis [31]-argues against 
antibiotic prophylaxis [32]. Children who attend day- 
care centers are at increased risk of colonization with 
multiple-resistant S. pneumoniae [31,33]; for them in 
particular, therefore, the drawbacks of a sustained 
lengthy antimicrobial prophylaxis potentially outweigh 
the likely benefits [32]. 
TYMPANOSTOMY TUBES 
The effectiveness of tympanostomy tubes seems ascrib- 
able to their success in keeping the middle ear well 
ventilated [24], which in turn appears to protect against 
infection. The efficacy of ventilating tubes in pre- 
venting new otitis episodes in children with recurrent 
AOM but without chronic secretory otitis media is 
lower than that of antibiotic prophylaxis [28]. More- 
over, offsetting the potential benefits of tube insertion 
are not only the operation’s risks and cost [24], but also 
its considerable number of complications and sequelae 
[34,35]. Nevertheless, tympanostomy tube placement 
represents the best surgical option for children with 
symptomatic persistent secretory otitis media and can 
be considered for children with many AOM recur- 
rences, despite having received appropriate antimicro- 
bial treatment for each otitis episode [23,36]. 
ADENOIDECTOMY 
Adenoidectomy is efficacious in some older children 
(4-8 years old) who continue suffering recurrent 
episodes of otitis media after tympanostomy tubes have 
been extruded [25,37]. The reason for the efficacy of 
adenoidectomy remains uncertain, but it seems that the 
removal of lymphoid tissue from near the eustachian 
tube orifice may result in improved middle ear ventila- 
tion or in the elimination of an important source of 
infection [24]. 
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Its beneficial effects, even though limited, are 
likely to last longer than those attained with tym- 
panostomy tubes, particularly for persistent secretory 
otitis media resolution [38]; moreover, properly 
performed, the procedure has no known or suspected 
long-term sequelae. However, it is a more major 
operation, entailing higher risk and cost than tym- 
panostomy [24]. 
VACCINES 
Active inimunization is a highly promising means of 
preventing AOM and thus blocking the sequence of 
pathologic events leading to recurrence and chronicity 
[25]. This preventive approach has become especially 
valuable with the increasing emergence of multiple- 
antibiotic-resistant bacteria. Vaccination strategies should 
be directed at the principal bacteria and viruses in- 
volved in AOM: s. pnenrnoniae, non-typeable H. 
infuenzae, Moraxella (Branhamella) catarvhalis, respiratory 
syncytial virus, parainfluenza virus, influenza virus and 
adenovirus [25]. 
At present, it is possible only to offer the pneumo- 
coccal vaccine for children over 2 years of age (current 
pneumococcal vaccines are not immunogenic in in- 
fants and toddlers) and the influenza vaccine for 
patients over 6 months [22]. Although the pneumo- 
coccal vaccine reduces the number of AOM episodes 
due to S. pneumoniae, there are conflicting data about 
its actual efficacy in preventing the recurrence of AOM 
overall [39,40]. The influenza vaccine decreased slightly 
the incidence of new episodes of AOM during an 
influenza A epidemic in Finland [41]. Nowadays, 
conjugate pneumococcal vaccines for overcoming im- 
munogenicity problems in infants, as well as several 
respiratory virus vaccines, are being developed [25,42]. 
CONCLUSIONS 
Certain primary interventions such as encouraging 
breast-feeding, using family or small-group day-care 
for infants and toddlers and avoiding exposure to 
household tobacco smoke, are the main preventive 
measures against AOM. It is also useful to immunize 
children who have recurrent otitis media with the 
currently available pneumococcal vaccine (after 2 years 
of age), as well as with the influenza vaccine. 
Given the rising prevalence of multiresistant 
bacteria, antibiotic prophylaxis should be used only in 
restricted situations, even though we know it is the 
most effective method to reduce the frequency of new 
episodes of otitis in children with recurrent AOM. At 
times, tympanostomy tube placement might be an 
option, and in children who persist in having AOM 
recurrences after tube extrusion, adenoidectomy can be 
considered. 
Therefore, antimicrobial treatment limited to each 
individual AOM episode and, in certain cases, anti- 
biotic prophylaxis for short periods, particularly when 
an upper respiratory tract infection is present, are 
now probably the best initial steps to take in order 
to prevent new episodes of otitis in children with 
recurrent AOM. 
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